Table 2.
Baseline stroke risk factors between groups
| Statins (n = 19) | Nonstatins (n = 78) | P value | |
|---|---|---|---|
| Age (years) | 61.1+/-8.6 | 65.4+/-8.5 | 0.048 |
| Male | 10 (53%) | 60 (78%) | 0.041 |
| Hemoglobin | 13.2+/-1.4 | 12.7+/-1.4 | 0.25 |
| Drinks (week) | 2.6+/-4.7 | 5.9+/-13.7 | 0.29 |
| Fibrinogen | 386+/-55 | 370+/-88 | 0.48 |
| High-density lipoproteins | 46.5+/-16.1 | 41.5+/-11.2 | 0.12 |
| Low-density lipoproteins | 130+/-39.7 | 154+/-45.3 | 0.049 |
| Triglycerides | 218+/-122 | 210+/-157 | 0.83 |
| Prior symptoms | 14 (74%) | 54 (70%) | 0.99 |
| Amaurosis | 3 | 12 | |
| Stroke | 5 | 29 | |
| Transient ischemic attack | 6 | 12 | |
| Ischemic optic neuropathy | 0 | 1 | 0.57 |
| Hypertension | 11 (58%) | 50 (65%) | 0.61 |
| Prior myocardial infarction | 3 (16)% | 17 (22%) | 0.53 |
| Diabetes | 4 (22%) | 22 (29%) | 0.50 |
| Smoking | |||
| Never | 2 | 11 | |
| Exsmoker | 10 | 34 | |
| Pipe (cigar) | 0 | 3 | |
| Cigarette | 7 | 29 | 0.77 |
| Family history | 4 (21%) | 17 (22%) | 0.99 |
| Medications | |||
| Antiplatelet | 13 (68%) | 59 (75%) | 0.55 |
| Coumadin | 7 (37%) | 24 (30%) | 0.55 |
| Calcium channel blocker | 5 (26%) | 30 (38%) | 0.28 |
| Angiotensin-converting enzyme inhibitor | 6 (32%) | 19 (24%) | 1.00 |
| Beta blocker | 5 (26%) | 14 (18%) | 0.73 |
| Alpha blocker | 0 | 3 (4%) | 1.00 |
| Pentoxifyllin | 1 (5%) | 6 (8%) | 1.00 |
| Dipyridamole | 1 (5%) | 2 (3%) | 0.46 |